1 |
孟琴琴,郭美亮,袁定芬, 等. SGK1功能的研究进展及临床意义 [J]. 医学综述, 2020, 26 (3): 427-432.
|
2 |
VASUDEVAN K M, BARBIE D A, DAVIES M A, et al. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer [J]. Cancer Cell, 2009, 16 (1): 21-32.
|
3 |
BRUHN M A, PEARSON R B, HANNAN R D,et al. AKT-independent PI3-K signaling in cancer-emerging role for SGK3 [J]. Cancer Manag Res, 2013, 5(5): 281-292.
|
4 |
AHMED M, FEZAI M, UZCATEGUI N L, et al. SGK3 Sensitivity of Voltage Gated K+ Channel Kv1.5 (KCNA5) [J]. Cell Physiol Biochem, 2016,38(1): 359-367.
|
5 |
LANG F, BöHMER C, PALMADA M, et al. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms [J]. Physiol Rev, 2006, 86 (4): 1151-1178.
|
6 |
HIRAOKA D, HOSODA E, CHIBA K, et al. SGK phosphorylates Cdc25 and Myt1 to trigger cyclin B–Cdk1 activation at the meiotic G2/M transition [J]. Cell Biol, 2019, 218 (11): 3597-3611.
|
7 |
LIU M, CHEN L, CHAN T H, et al. Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma [J]. Hepatology, 2012, 55 (6): 1754-1765.
|
8 |
HOU M, LAI Y, HE S, et al. SGK3 (CISK) may induce tumor angiogenesis (Hypothesis) [J]. Oncol Lett, 2015, 10 (1): 23-26.
|
9 |
LANG F, COHEN P. Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms [J]. Sci STKE, 2001, 2001 (108): re17.
|
10 |
郭红艳,孙晓杰,刘秀财,等 .蛋白激酶SGK3过表达对乳腺癌细胞株MDA-MB-231影响的研究[J].中华肿瘤防治杂志,2016,23 (24):1601-1606.
|
11 |
GONG G Q, WANG K, DAI X C,et al. Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds [J]. Acta Pharmacol Sin, 2018, 39 (12): 1902-1912.
|
12 |
BASNET R, GONG G Q, LI C, et al. Serum and glucocorticoid inducible protein kinases (SGKs):a potential target for cancer intervention [J]. Acta Pharm Sin B, 2018, 8 (5): 767-771.
|
13 |
CHEN Y, SUN Z, QI M, et al. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway [J]. J Cell Mol Med,2018,22(5): 2935-2943.
|
14 |
MALIK N, MACARTNEY T, HORNBERGER A, et al. Mechanism of activation of SGK3 by growth factors via the Class 1 and Class 3 PI3Ks [J]. Biochem J, 2018, 475 (1): 117-135.
|
15 |
BRUHN M A, PEARSON R B, HANNAN R D,et al. Second AKT: the rise of SGK in cancer signalling[J]. Growth Factors, 2010, 28 (6): 394-408.
|
16 |
LIEN E C, DIBBLE C C, TOKER A. PI3K signaling in cancer: beyond AKT [J]. Curr Opin Cell Biol, 2017, 45 (45): 62-71.
|
17 |
BAGO R, SOMMER E, CASTEL P, et al. The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth [J]. EMBO J, 2016, 35 (17): 1902-1922.
|
18 |
VIRBASIUS J V, SONG X, POMERLEAU D P,et al. Activation of the Akt-related cytokine-independent survival kinase requires interaction of its phox domain with endosomal phosphatidylinositol 3-phosphate [J]. Proc Natl Acad Sci U S A, 2001,98(23): 12908-12913.
|
19 |
XU J, LIU D, GILL G, et al. Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides [J]. J Cell Biol, 2001, 154 (4): 699-705.
|
20 |
SCHULTE L A, LÓPEZ-GIL J C, SAINZ B Jr, et al. The Cancer Stem Cell in Hepatocellular Carcinoma[J]. Cancers (Basel), 2020, 12 (3): 684.
|
21 |
MITRA A, MISHRA L, LI S. EMT, CTCs and CSCs in tumor relapse and drug-resistance [J]. Oncotarget, 2015, 6 (13): 10697-10711.
|
22 |
HOSODA E, HIRAOKA D, HIROHASHI N, et al. SGK regulates pH increase and cyclin B-Cdk1 activation to resume meiosis in starfish ovarian oocytes[J]. Cell Biol, 2019, 218 (11): 3612-3629.
|
23 |
KONG X, LIU F, GAO J. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways[J]. Oncotarget, 2016, 7(40): 66051-66060.
|
24 |
CAO H, XU Z, WANG J, et al. Functional role of SGK3 in PI3K/Pten driven liver tumor development [J]. BMC Cancer, 2019,19(1):343.
|
25 |
TESSIER M, WOODGETT J R. Serum and glucocorticoid-regulated protein kinases: variations on a theme [J]. J Cell Biochem, 2006, 98 (6): 1391-1407.
|
26 |
LIU F, WU X, QIAN Y, et al. PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor [J]. Cell Death Dis, 2020, 11 (6): 427.
|
27 |
LIU F, WU X, JIANG X, et al. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling [J]. J Exp Clin Cancer Res, 2018, 37 (1): 122.
|
28 |
WU M, HUANG C, HUANG X, et al. MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma [J]. Oncol Rep, 2017, 38 (4): 2173-2181.
|
29 |
WANG Y, ZHOU D, PHUNG S, et al. SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis [J]. Proc Natl Acad Sci U S A, 2017,114 (8):E1500-E1508.
|
30 |
TOVELL H, TESTA A, ZHOU H, et al. Design and Characterization of SGK3-PROTAC1, an isoform specific SGK3 kinase PROTAC degrader [J]. ACS Chem Biol, 2019, 14 (9): 2024-2034.
|
31 |
SUN X, LIU X, LIU B O, et al. Serum- and glucocorticoid-regulated protein kinase 3 overexpression promotes tumor development and aggression in breast cancer cells [J]. Oncol Lett, 2016, 12 (1): 437-444.
|
32 |
WANG Y, ZHOU D, PHUNG S, et al. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells [J]. Mol Endocrinol, 2011, 25 (1): 72-82.
|
33 |
XU J, LIAO L, QIN J, et al. Identification of Flightless-I as a substrate of the cytokine-independent survival kinase CISK[J].J Biol Chem,2009,284(21):14377-14385.
|
34 |
WANG H, HUANG F, ZHANG Z, et al. Feedback activation of SGK3 and AKT contributes to rapamycin resistance by reactivating mTORC1/4EBP1 axis via TSC2 in breast cancer [J]. Int J Biol Sci, 2019, 15 (5): 929-941.
|
35 |
SHERK A B, FRIGO D E, SCHNACKENBERG C G,et al. Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic [J]. Cancer Res, 2008, 68 (18): 7475-7483.
|
36 |
WANG Y, ZHOU D, CHEN S. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1[J].Mol Endocrinol,2014,28 (6): 935-948.
|
37 |
SHARMA N L, MASSIE C E, RAMOS-MONTOYA A,et al. The androgen re-ceptor induces a distinct transcriptional program in castration-re-sistant prostate cancer in man [J]. Cancer Cell, 2013, 23 (1): 35-47.
|
38 |
NALAIRNDRAN G, HASSAN ABDUL RAZACK A, MAI C W,et al. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival [J]. J Cell Mol Med, 2020, 24 (20): 12188-12198.
|
39 |
WANG Y, XU W, ZHOU D, et al. Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complex [J]. J Biol Chem, 2014, 289 (8): 4815-4826.
|
40 |
LIU H, LI C, SHEN C, et al. MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3 [J]. J Neurooncol, 2015, 122 (3): 431-439.
|
41 |
JU C, ZHOU R, SUN J, et al. LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis [J]. Cancer Cell Int, 2018, 18 (18): 141.
|
42 |
FAN X R, ZHANG Z Y, WANG R H, et al. MiR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma [J]. Eur Rev Med Pharmacol Sci, 2019, 23 (9): 3726-3732.
|
43 |
ZHENG H, WU L, WANG X, et al. Risk of nasopharyngeal carcinoma associated with single nucleotide polymorphisms in the microRNA binding site of SGK3[J].Genet Test Mol Biomarkers,2020,24(8): 508-519.
|
44 |
MALIK N, NIRUJOGI R S, PELTIER J, et al. Phosphoproteomics reveals that the hVPS34 regulated SGK3 kinase specifically phosphorylates endosomal proteins including Syntaxin-7, Syntaxin-12, RFIP4 and WDR44 [J]. Biochem J, 2019, 476 (20): 3081-3107.
|